TNXP
Tonix Pharmaceuticals Holding Corp
Price:  
0.14 
USD
Volume:  
14,407,216.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

TNXP WACC - Weighted Average Cost of Capital

The WACC of Tonix Pharmaceuticals Holding Corp (TNXP) is 6.3%.

The Cost of Equity of Tonix Pharmaceuticals Holding Corp (TNXP) is 8.35%.
The Cost of Debt of Tonix Pharmaceuticals Holding Corp (TNXP) is 7.00%.

Range Selected
Cost of equity 6.90% - 9.80% 8.35%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 7.00% - 7.00% 7.00%
WACC 5.8% - 6.8% 6.3%
WACC

TNXP WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.65 0.87
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.90% 9.80%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1.77 1.77
Cost of debt 7.00% 7.00%
After-tax WACC 5.8% 6.8%
Selected WACC 6.3%